Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL269277 (ALS-357, .beta.-betulinic acid, Betulic acid, Betulinic acid, Lupatic acid, Mairin, NSC-113090, NSC-677578) |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| Ecto-5'-Nucleotidase/5`-nucleotidase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5957] [GtoPdb: 1232] [UniProtKB: P21589] | ||||||||
| ChEMBL | Binding affinity to CD73 (unknown origin) assessed as inhibition constant | B | 5.11 | pKi | 7800 | nM | Ki | Eur J Med Chem (2023) 258: 115546-115546 [PMID:37302340] |
| ChEMBL | Inhibition of human CD73 assessed as reduction in inorganic phosphate release upon substrate hydrolysis using AMP/ATP as substrate incubated for 1 hr followed by substrate addition and measured after 2 hrs by malachite green reagent based colorimetric assay | B | 5.14 | pIC50 | 7280 | nM | IC50 | Bioorg Med Chem (2022) 59: 116672-116672 [PMID:35217359] |
| ChEMBL | Inhibition of CD73 (unknown origin) | B | 5.14 | pIC50 | 7280 | nM | IC50 | Eur J Med Chem (2023) 258: 115546-115546 [PMID:37302340] |
| Ecto-5'-Nucleotidase/5`-nucleotidase in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4680034] [GtoPdb: 1232] [UniProtKB: Q61503] | ||||||||
| ChEMBL | Inhibition of mouse CD73 assessed as reduction in inorganic phosphate release upon substrate hydrolysis using AMP/ATP as substrate incubated for 1 hr followed by substrate addition and measured after 2 hrs by malachite green reagent based colorimetric assay | B | 4.16 | pIC50 | 68790 | nM | IC50 | Bioorg Med Chem (2022) 59: 116672-116672 [PMID:35217359] |
| aldo-keto reductase family 1 member B/Aldo-keto reductase family 1 member B1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1900] [GtoPdb: 2768] [UniProtKB: P15121] | ||||||||
| ChEMBL | Inhibition of reductase activity of N-terminal 6His-tagged human recombinant AKR1B1 expressed in Escherichia coli BL21(DE3) assessed as assessed as pyridine-3-aldehyde reduction | B | 4.96 | pIC50 | 11000 | nM | IC50 | J Nat Prod (2011) 74: 1201-1206 [PMID:21561086] |
| Aldo-keto reductase family 1 member B10 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5983] [UniProtKB: O60218] | ||||||||
| ChEMBL | Inhibition of reductase activity of N-terminal 6His-tagged human AKR1B10 expressed in Escherichia coli BL21(DE3) assessed as pyridine-3-aldehyde reduction | B | 5.7 | pIC50 | 2000 | nM | IC50 | J Nat Prod (2011) 74: 1201-1206 [PMID:21561086] |
| Botulinum neurotoxin type A in Clostridium botulinum (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5192] [UniProtKB: P0DPI0] | ||||||||
| ChEMBL | Inhibition of Clostridium BoNT/A protease light chain | B | 4.84 | pKi | 14300 | nM | Ki | Bioorg Med Chem Lett (2011) 21: 2229-2231 [PMID:21421315] |
| ChEMBL | Inhibition of Clostridium BoNT/A protease light chain | B | 4.7 | pIC50 | 20000 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 2229-2231 [PMID:21421315] |
| dipeptidyl peptidase 4/Dipeptidyl peptidase 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL284] [GtoPdb: 1612] [UniProtKB: P27487] | ||||||||
| ChEMBL | Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay | B | 4.25 | pIC50 | 55820 | nM | IC50 | Medchemcomm (2011) 2: 471-477 |
| DNA polymerase beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2392] [GtoPdb: 3231] [UniProtKB: P06746] | ||||||||
| ChEMBL | Inhibition of polymerase activity of DNA polymerase beta | B | 4.33 | pIC50 | 46250 | nM | IC50 | Bioorg Med Chem (2008) 16: 4331-4340 [PMID:18343122] |
| ChEMBL | Inhibition of DNA polymerase beta lyase activity by deoxyribose phosphate excision assay | B | 4.36 | pIC50 | 43600 | nM | IC50 | J Nat Prod (2003) 66: 1463-1465 [PMID:14640519] |
| ChEMBL | Inhibition of lyase activity of DNA polymerase beta | B | 4.47 | pIC50 | 33700 | nM | IC50 | Bioorg Med Chem (2008) 16: 4331-4340 [PMID:18343122] |
| DNA polymerase beta in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4343] [GtoPdb: 3231] [UniProtKB: P06766] | ||||||||
| ChEMBL | Inhibition of rat DNA polymerase beta in presence of 0.1 mg/mL BSA | B | 4.85 | pIC50 | 14000 | nM | IC50 | J Nat Prod (1999) 62: 1660-1663 [PMID:10654414] |
| ChEMBL | Inhibition of rat DNA polymerase beta in absence of BSA | B | 5.19 | pIC50 | 6500 | nM | IC50 | J Nat Prod (1999) 62: 1660-1663 [PMID:10654414] |
| Glycogen phosphorylase, muscle form in Rabbit (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4696] [UniProtKB: P00489] | ||||||||
| ChEMBL | Inhibition of rabbit muscle glycogen phosphorylase A assessed as phosphate release from glucose-1-phosphate | B | 4.37 | pIC50 | 43000 | nM | IC50 | J Med Chem (2008) 51: 3540-3554 [PMID:18517260] |
| ChEMBL | Inhibition of rabbit muscle glycogen phosphorylase A assessed as release of phosphate from glucose-1-phosphate after 25 mins by microplate reader based method | B | 4.37 | pIC50 | 43000 | nM | IC50 | Eur J Med Chem (2011) 46: 2011-2021 [PMID:21439694] |
| ChEMBL | Inhibition of rabbit muscle glycogen phosphorylase A assessed as release of phosphate from glucose-1-phosphate after 25 mins by microplate reader based method | B | 4.37 | pIC50 | 42657.95 | nM | IC50 | Eur J Med Chem (2011) 46: 2011-2021 [PMID:21439694] |
| GP41 in Human immunodeficiency virus 1 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3559676] [UniProtKB: Q76270] | ||||||||
| ChEMBL | Inhibition of HIV1 gp41-induced cell-cell fusion between viral envelope expressing human HL2/3 cells to CD4/CCR5 receptor expressing TZM-bl cells after 6 to 8 hrs by luciferase assay | B | 4 | pEC50 | >100000 | nM | EC50 | J Med Chem (2014) 57: 7342-7354 [PMID:25156906] |
| GPBA receptor/G-protein coupled bile acid receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5409] [GtoPdb: 37] [UniProtKB: Q8TDU6] | ||||||||
| GtoPdb | - | - | 5.98 | pEC50 | 1040 | nM | EC50 | J Med Chem (2010) 53: 178-90 [PMID:19911773] |
| ChEMBL | Agonist activity at TGR5 expressed in CHO cells by CRE-driven luciferase reporter gene assay | F | 5.98 | pEC50 | 1040 | nM | EC50 | J Med Chem (2010) 53: 178-190 [PMID:19911773] |
| ChEMBL | Agonist activity at TGR5 (unknown origin) expressed in CHO cells assessed as activation of intracellular cAMP production by luciferase reporter gene assay | F | 5.99 | pEC50 | 1030 | nM | EC50 | Eur J Med Chem (2024) 271: 116462-116462 [PMID:38691888] |
| Nonstructural protein 5 in Dengue virus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4295629] [UniProtKB: V5TFZ2] | ||||||||
| ChEMBL | Inhibition of dengue virus NS5 RNA dependent RNA polymerase | B | 5.77 | pIC50 | 1700 | nM | IC50 | Eur J Med Chem (2019) 176: 431-455 [PMID:31128447] |
| ChEMBL | Inhibition of DENV/NS5 RNA-dependent RNA polymerase | B | 5.77 | pIC50 | 1700 | nM | IC50 | Eur J Med Chem (2023) 256: 115416-115416 [PMID:37159959] |
| RAR-related orphan receptor-γ/Nuclear receptor ROR-gamma in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1741186] [GtoPdb: 600] [UniProtKB: P51449] | ||||||||
| ChEMBL | Binding affinity to ROR-gamma LBD (unknown origin) assessed as dissociation constant by ITC analysis | B | 5.47 | pKd | 3390 | nM | Kd | Eur J Med Chem (2023) 257: 115472-115472 [PMID:37236000] |
| ChEMBL | Binding affinity to CM5 chip-immobilized recombinant ROR-gamma LBD (unknown origin) assessed as dissociation constant by SPR analysis | B | 5.57 | pKd | 2700 | nM | Kd | Eur J Med Chem (2023) 257: 115472-115472 [PMID:37236000] |
| ChEMBL | Antagonist activity at ROR-gamma LBD (unknown origin) using biotinylated SRC1-2 as substrate preincubated for 60 mins followed by substrate addition measured after 30 mins by HTRF assay | B | 5.66 | pIC50 | 2200 | nM | IC50 | Eur J Med Chem (2023) 257: 115472-115472 [PMID:37236000] |
| Liver X receptor-α/Oxysterols receptor LXR-alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2808] [GtoPdb: 602] [UniProtKB: Q13133] | ||||||||
| ChEMBL | Agonist activity at human recombinant LXRalpha expressed in Escherichia coli BL21 cells assessed as association of recombinant SRC1 to LXRalpha ligand binding domain by HTRF assay | B | 4.3 | pEC50 | >50000 | nM | EC50 | J Nat Prod (2005) 68: 1247-1252 [PMID:16124770] |
| Liver X receptor-β/Oxysterols receptor LXR-beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4093] [GtoPdb: 601] [UniProtKB: P55055] | ||||||||
| ChEMBL | Agonist activity at human recombinant LXRbeta expressed in Escherichia coli BL21 cells assessed as association of recombinant SRC1 to LXRbeta ligand binding domain by HTRF assay | B | 4.3 | pEC50 | >50000 | nM | EC50 | J Nat Prod (2005) 68: 1247-1252 [PMID:16124770] |
| Peroxisome proliferator-activated receptor-γ/Peroxisome proliferator-activated receptor gamma in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2459] [GtoPdb: 595] [UniProtKB: P37238] | ||||||||
| ChEMBL | Agonist activity at mouse PPARgamma expressed in HEK293 cells co-expressing with Gal4 reporter vector after 24 hrs by dual-luciferase reporter assay | B | 4 | pEC50 | >100000 | nM | EC50 | J Nat Prod (2014) 77: 1594-1600 [PMID:24955889] |
| Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364] | ||||||||
| ChEMBL | Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 infected in human erythrocytes | F | 4.89 | pIC50 | 12780 | nM | IC50 | Bioorg Med Chem Lett (2018) 28: 265-272 [PMID:29326018] |
| ChEMBL | Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 rings after 48 hrs by FACS analysis | F | 5.28 | pIC50 | 5200 | nM | IC50 | J Nat Prod (2009) 72: 2130-2134 [PMID:19904919] |
| ChEMBL | Antiplasmodial activity against Plasmodium falciparum Dd2 incubated under low oxygen conditions after 72 hrs by SYBR green assay | F | 5.46 | pIC50 | 3440 | nM | IC50 | Bioorg Med Chem (2016) 24: 2544-2548 [PMID:27112454] |
| ChEMBL | Antimalarial activity against ring stage Plasmodium falciparum 3D7 infected in type A-positive human erythrocytes after 72 hrs by SYBR green 1 dye-based fluorescence assay | F | 5.85 | pEC50 | 1419 | nM | EC50 | Bioorg Med Chem (2019) 27: 110-115 [PMID:30503412] |
| CoV 3C-like (main) protease/CoV Replicase polyprotein 1a/Replicase polyprotein 1a in Severe acute respiratory syndrome-related coronavirus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3927] [GtoPdb: 3111, 3124] [UniProtKB: P0C6U8] | ||||||||
| ChEMBL | Inhibition of SARS coronavirus 3CL protease | B | 5.09 | pKi | 8200 | nM | Ki | J Med Chem (2007) 50: 4087-4095 [PMID:17663539] |
| ChEMBL | Inhibition of SARS coronavirus 3CL protease | B | 5 | pIC50 | 10000 | nM | IC50 | J Med Chem (2007) 50: 4087-4095 [PMID:17663539] |
| CoV Replicase polyprotein 1ab/CoV RNA-dependent RNA polymerase/CoV Non-structural protein 15/CoV Non-structural protein 13/Replicase polyprotein 1ab in Severe acute respiratory syndrome coronavirus 2 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523582] [GtoPdb: 3125, 3139, 3206, 3261] [UniProtKB: P0DTD1] | ||||||||
| ChEMBL | Inhibition of SARS-CoV-2 MPro using Dabcyl-KTSAVLQSGFRKME-Edans as substrate preincubated for 30 mins followed by substrate addition measured after 15 mins by FRET assay | B | 5 | pIC50 | 10000 | nM | IC50 | Eur J Med Chem (2023) 260: 115772-115772 [PMID:37659195] |
| RELA proto-oncogene, NF-kB subunit/Transcription factor p65 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5533] [GtoPdb: 3280] [UniProtKB: Q04206] | ||||||||
| ChEMBL | Inhibition of biotinylated consensus sequence binding to NF-kB p65 in human HeLa nuclear extracts after 3 hrs by ELISA | B | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem (2018) 26: 4452-4460 [PMID:30057155] |
| protein tyrosine phosphatase non-receptor type 1/Tyrosine-protein phosphatase non-receptor type 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL335] [GtoPdb: 2976] [UniProtKB: P18031] | ||||||||
| ChEMBL | Inhibition of PTP1B (unknown origin) | B | 5.82 | pIC50 | 1500 | nM | IC50 | Bioorg Med Chem (2021) 44: 116295-116295 [PMID:34246920] |
| Zinc finger protein GLI1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5461] [UniProtKB: P08151] | ||||||||
| ChEMBL | Inhibition of GLI1-mediated transcriptional activity in human HaCaT cells by luciferase based reporter gene assay | B | 4.49 | pIC50 | 32000 | nM | IC50 | Bioorg Med Chem (2008) 16: 9420-9424 [PMID:18842418] |
| ChEMBL | Inhibition of Gli1-mediated transcription expressed in human PANC1 cells | B | 4.49 | pIC50 | 32000 | nM | IC50 | J Med Chem (2009) 52: 3829-3845 [PMID:19309080] |
ChEMBL data shown on this page come from version 36:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]